Plasma and Intrapulmonary Pharmacokinetics of Ceftibuten and Ledaborbactam in Healthy Male and Female Participants 18 to ≤55 Years of Age
Clinical trial NCT06665555 · COMPLETED
Trial details
- NCT number
- NCT06665555
- Sponsor
- Basilea Pharmaceutica
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-11-04
- Primary completion
- 2025-03-13
- Enrollment
- 34
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.